Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Membrane Fusion | 16 | 2016 | 29 | 2.880 |
Why?
|
Cell Membrane | 12 | 2018 | 91 | 2.300 |
Why?
|
Membrane Lipids | 11 | 2016 | 15 | 2.250 |
Why?
|
Models, Biological | 11 | 2016 | 329 | 1.670 |
Why?
|
Lipid Bilayers | 11 | 2016 | 51 | 1.620 |
Why?
|
Viral Fusion Proteins | 7 | 2020 | 15 | 1.500 |
Why?
|
Models, Chemical | 6 | 2016 | 43 | 1.240 |
Why?
|
Membrane Microdomains | 5 | 2008 | 10 | 1.170 |
Why?
|
Virus Internalization | 7 | 2021 | 19 | 1.150 |
Why?
|
HIV-1 | 7 | 2011 | 235 | 1.140 |
Why?
|
HIV Envelope Protein gp41 | 5 | 2011 | 12 | 0.970 |
Why?
|
Membrane Fluidity | 4 | 2008 | 6 | 0.910 |
Why?
|
Intestinal Mucosa | 3 | 2011 | 191 | 0.830 |
Why?
|
Light | 4 | 2011 | 80 | 0.810 |
Why?
|
Viral Envelope Proteins | 6 | 2021 | 15 | 0.720 |
Why?
|
Cholesterol | 4 | 2018 | 55 | 0.720 |
Why?
|
Membrane Proteins | 5 | 2019 | 173 | 0.700 |
Why?
|
Models, Molecular | 5 | 2011 | 87 | 0.700 |
Why?
|
Membrane Potentials | 3 | 2010 | 171 | 0.660 |
Why?
|
Ebolavirus | 2 | 2016 | 6 | 0.650 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2011 | 69 | 0.620 |
Why?
|
Precancerous Conditions | 2 | 2010 | 24 | 0.610 |
Why?
|
Erythrocytes | 2 | 2018 | 19 | 0.610 |
Why?
|
beta-Cyclodextrins | 1 | 2018 | 3 | 0.600 |
Why?
|
Algorithms | 8 | 2008 | 371 | 0.550 |
Why?
|
Breast Neoplasms | 4 | 2018 | 417 | 0.540 |
Why?
|
Cells | 1 | 2016 | 3 | 0.530 |
Why?
|
Viruses | 1 | 2016 | 6 | 0.530 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 7 | 0.520 |
Why?
|
Cell Line | 9 | 2015 | 286 | 0.510 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 11 | 0.510 |
Why?
|
Semliki forest virus | 2 | 2007 | 3 | 0.500 |
Why?
|
Animals | 16 | 2021 | 3824 | 0.480 |
Why?
|
Thermodynamics | 5 | 2018 | 43 | 0.470 |
Why?
|
Water | 2 | 2011 | 32 | 0.460 |
Why?
|
Hydrogen-Ion Concentration | 9 | 2016 | 136 | 0.450 |
Why?
|
Cell Fusion | 4 | 2010 | 10 | 0.450 |
Why?
|
Viral Proteins | 2 | 2013 | 13 | 0.450 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 26 | 0.440 |
Why?
|
Endosomes | 3 | 2021 | 7 | 0.420 |
Why?
|
Gene Products, env | 4 | 2009 | 14 | 0.410 |
Why?
|
Peptide Fragments | 2 | 2011 | 78 | 0.410 |
Why?
|
Protein Transport | 2 | 2019 | 33 | 0.410 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 4 | 2016 | 12 | 0.390 |
Why?
|
Microfluidics | 1 | 2011 | 7 | 0.390 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 3 | 0.380 |
Why?
|
Fiber Optic Technology | 1 | 2011 | 7 | 0.370 |
Why?
|
Epithelium | 1 | 2011 | 27 | 0.370 |
Why?
|
Endocytosis | 1 | 2011 | 16 | 0.370 |
Why?
|
Liposomes | 5 | 2016 | 13 | 0.360 |
Why?
|
Carcinoma in Situ | 1 | 2010 | 10 | 0.360 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2004 | 189 | 0.350 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 70 | 0.350 |
Why?
|
HEK293 Cells | 5 | 2021 | 69 | 0.350 |
Why?
|
Humans | 27 | 2021 | 28054 | 0.340 |
Why?
|
Porosity | 3 | 2016 | 60 | 0.340 |
Why?
|
CD4 Antigens | 4 | 2005 | 29 | 0.340 |
Why?
|
Colonic Neoplasms | 2 | 2011 | 61 | 0.340 |
Why?
|
Scattering, Radiation | 6 | 2011 | 37 | 0.330 |
Why?
|
Stochastic Processes | 4 | 2011 | 13 | 0.330 |
Why?
|
HIV | 1 | 2009 | 41 | 0.320 |
Why?
|
Photometry | 1 | 2008 | 1 | 0.310 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 113 | 0.310 |
Why?
|
Irritable Bowel Syndrome | 1 | 2008 | 8 | 0.310 |
Why?
|
Protein Folding | 3 | 2005 | 20 | 0.310 |
Why?
|
Computer Simulation | 5 | 2011 | 205 | 0.300 |
Why?
|
Virion | 4 | 2020 | 14 | 0.290 |
Why?
|
Brain Mapping | 2 | 1998 | 168 | 0.280 |
Why?
|
Biophysics | 1 | 2007 | 33 | 0.280 |
Why?
|
Brain | 3 | 2004 | 1690 | 0.280 |
Why?
|
Lipid Peroxides | 1 | 2006 | 2 | 0.270 |
Why?
|
Flow Cytometry | 3 | 2016 | 116 | 0.270 |
Why?
|
Imaging, Three-Dimensional | 2 | 2006 | 229 | 0.260 |
Why?
|
Spectrum Analysis | 1 | 2006 | 8 | 0.260 |
Why?
|
Energy Transfer | 3 | 2004 | 5 | 0.260 |
Why?
|
COS Cells | 5 | 2021 | 40 | 0.250 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2005 | 16 | 0.250 |
Why?
|
Colitis | 1 | 2006 | 37 | 0.250 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 9 | 0.250 |
Why?
|
Influenza A virus | 4 | 2019 | 15 | 0.250 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 78 | 0.240 |
Why?
|
Ultrasonography, Mammary | 4 | 2008 | 10 | 0.240 |
Why?
|
Lipids | 3 | 2011 | 43 | 0.230 |
Why?
|
Nonlinear Dynamics | 1 | 2004 | 13 | 0.230 |
Why?
|
Lassa virus | 2 | 2021 | 4 | 0.230 |
Why?
|
Protein Conformation | 7 | 2008 | 75 | 0.230 |
Why?
|
Orthomyxoviridae | 2 | 2001 | 2 | 0.230 |
Why?
|
Amino Acid Sequence | 6 | 2011 | 154 | 0.220 |
Why?
|
Molecular Sequence Data | 6 | 2011 | 196 | 0.220 |
Why?
|
Temperature | 4 | 2007 | 67 | 0.220 |
Why?
|
Sphingolipids | 1 | 2002 | 3 | 0.210 |
Why?
|
Molecular Conformation | 3 | 2008 | 10 | 0.210 |
Why?
|
Rats | 5 | 2011 | 675 | 0.210 |
Why?
|
Antiviral Agents | 2 | 2020 | 71 | 0.200 |
Why?
|
Lassa Fever | 1 | 2021 | 2 | 0.190 |
Why?
|
Monoglycerides | 1 | 2021 | 2 | 0.190 |
Why?
|
Lysophospholipids | 1 | 2021 | 3 | 0.190 |
Why?
|
Sensitivity and Specificity | 4 | 2011 | 511 | 0.180 |
Why?
|
Mutation | 3 | 2016 | 358 | 0.180 |
Why?
|
Colicins | 4 | 1995 | 4 | 0.180 |
Why?
|
Elasticity | 3 | 2015 | 34 | 0.180 |
Why?
|
DNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
RNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
RNA Viruses | 1 | 2020 | 4 | 0.170 |
Why?
|
Salicylates | 1 | 2020 | 6 | 0.170 |
Why?
|
DNA Viruses | 1 | 2020 | 6 | 0.170 |
Why?
|
Fluorescent Dyes | 4 | 2010 | 38 | 0.170 |
Why?
|
Ultrasonography | 1 | 2001 | 232 | 0.160 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 25 | 0.160 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 119 | 0.150 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 102 | 0.150 |
Why?
|
Models, Statistical | 2 | 2008 | 128 | 0.140 |
Why?
|
Pattern Recognition, Automated | 2 | 2008 | 7 | 0.140 |
Why?
|
Patch-Clamp Techniques | 2 | 2016 | 102 | 0.140 |
Why?
|
Protein Structure, Tertiary | 2 | 2009 | 63 | 0.140 |
Why?
|
Ion Channels | 3 | 1995 | 217 | 0.130 |
Why?
|
Membranes | 1 | 2016 | 9 | 0.130 |
Why?
|
Hemagglutinins | 1 | 1996 | 1 | 0.130 |
Why?
|
Cathepsins | 1 | 2016 | 4 | 0.130 |
Why?
|
Stress, Mechanical | 2 | 2008 | 167 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 58 | 0.130 |
Why?
|
Blotting, Western | 1 | 2016 | 149 | 0.130 |
Why?
|
Signal Transduction | 1 | 2018 | 455 | 0.120 |
Why?
|
Detergents | 2 | 2007 | 4 | 0.120 |
Why?
|
Immunohistochemistry | 1 | 2016 | 366 | 0.120 |
Why?
|
Exocytosis | 2 | 1993 | 4 | 0.120 |
Why?
|
Mice | 4 | 2008 | 1494 | 0.110 |
Why?
|
Structure-Activity Relationship | 2 | 2004 | 41 | 0.110 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 2013 | 5 | 0.110 |
Why?
|
Time Factors | 2 | 2010 | 1485 | 0.110 |
Why?
|
Surface Tension | 2 | 2015 | 3 | 0.110 |
Why?
|
Protein Structure, Secondary | 2 | 2011 | 20 | 0.110 |
Why?
|
Phantoms, Imaging | 2 | 2010 | 39 | 0.110 |
Why?
|
Antigens, Differentiation | 1 | 2013 | 10 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2008 | 715 | 0.110 |
Why?
|
Kinetics | 3 | 2009 | 185 | 0.100 |
Why?
|
Virus Replication | 2 | 2020 | 51 | 0.100 |
Why?
|
Amino Acid Substitution | 2 | 2011 | 28 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2006 | 83 | 0.100 |
Why?
|
Viscosity | 1 | 2011 | 9 | 0.100 |
Why?
|
Friction | 1 | 2011 | 20 | 0.100 |
Why?
|
Diffusion | 1 | 2011 | 24 | 0.100 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2011 | 1 | 0.090 |
Why?
|
Protein Stability | 1 | 2011 | 6 | 0.090 |
Why?
|
Entropy | 1 | 2011 | 5 | 0.090 |
Why?
|
Biomechanical Phenomena | 1 | 2013 | 670 | 0.090 |
Why?
|
Drug Synergism | 1 | 2011 | 41 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 34 | 0.090 |
Why?
|
Drug Resistance, Viral | 1 | 2011 | 14 | 0.090 |
Why?
|
Peptides | 2 | 2009 | 109 | 0.090 |
Why?
|
Rabbits | 1 | 2011 | 193 | 0.090 |
Why?
|
HeLa Cells | 3 | 2005 | 42 | 0.090 |
Why?
|
Microscopy, Fluorescence | 2 | 2006 | 79 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 32 | 0.090 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 56 | 0.090 |
Why?
|
Fluorescence | 1 | 2010 | 10 | 0.090 |
Why?
|
Electricity | 1 | 2010 | 8 | 0.090 |
Why?
|
Biopsy | 1 | 2011 | 218 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2010 | 67 | 0.090 |
Why?
|
Mutagenesis | 1 | 2009 | 13 | 0.080 |
Why?
|
Electrophysiology | 2 | 2007 | 99 | 0.080 |
Why?
|
Image Enhancement | 2 | 2008 | 48 | 0.080 |
Why?
|
Intracellular Membranes | 2 | 2007 | 21 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 3 | 1998 | 336 | 0.080 |
Why?
|
Radio Waves | 3 | 2008 | 9 | 0.080 |
Why?
|
Wettability | 1 | 2008 | 1 | 0.080 |
Why?
|
Receptors, CCR5 | 2 | 2005 | 14 | 0.080 |
Why?
|
Potassium | 2 | 2002 | 65 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2006 | 34 | 0.070 |
Why?
|
Reference Values | 2 | 1998 | 201 | 0.070 |
Why?
|
Carcinoma, Ductal | 1 | 2008 | 5 | 0.070 |
Why?
|
Receptors, CXCR4 | 2 | 2005 | 17 | 0.070 |
Why?
|
Electric Capacitance | 1 | 2007 | 6 | 0.070 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 57 | 0.070 |
Why?
|
Permeability | 1 | 2007 | 120 | 0.070 |
Why?
|
Anisotropy | 1 | 2007 | 53 | 0.070 |
Why?
|
Phosphatidylethanolamines | 1 | 2006 | 2 | 0.070 |
Why?
|
Photobleaching | 1 | 2006 | 2 | 0.070 |
Why?
|
Sphingomyelins | 1 | 2006 | 5 | 0.070 |
Why?
|
Spectrometry, Fluorescence | 1 | 2006 | 9 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2008 | 372 | 0.070 |
Why?
|
Electrochemistry | 1 | 2006 | 43 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 65 | 0.070 |
Why?
|
HIV Fusion Inhibitors | 1 | 2005 | 2 | 0.060 |
Why?
|
Gene Deletion | 1 | 2005 | 41 | 0.060 |
Why?
|
Cryoultramicrotomy | 1 | 2004 | 1 | 0.060 |
Why?
|
Biomedical Engineering | 2 | 2001 | 5 | 0.060 |
Why?
|
Female | 4 | 2018 | 15534 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2004 | 20 | 0.060 |
Why?
|
HIV Infections | 1 | 2009 | 481 | 0.060 |
Why?
|
Trypan Blue | 1 | 2002 | 1 | 0.050 |
Why?
|
Hydrogen Bonding | 1 | 2002 | 3 | 0.050 |
Why?
|
Zinc | 1 | 2002 | 40 | 0.050 |
Why?
|
Hemorrhoids | 1 | 2001 | 1 | 0.050 |
Why?
|
Micelles | 1 | 2001 | 1 | 0.050 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 1 | 0.050 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2001 | 3 | 0.050 |
Why?
|
Vero Cells | 1 | 2020 | 8 | 0.040 |
Why?
|
DNA Replication | 1 | 2020 | 10 | 0.040 |
Why?
|
DNA, Viral | 1 | 2020 | 42 | 0.040 |
Why?
|
Point Mutation | 1 | 1999 | 27 | 0.040 |
Why?
|
Interferons | 1 | 2019 | 8 | 0.040 |
Why?
|
A549 Cells | 1 | 2019 | 10 | 0.040 |
Why?
|
Optical Imaging | 1 | 2019 | 6 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 14 | 0.040 |
Why?
|
Artifacts | 1 | 1998 | 33 | 0.040 |
Why?
|
Biological Transport | 3 | 1995 | 40 | 0.040 |
Why?
|
Astrocytes | 1 | 2020 | 150 | 0.040 |
Why?
|
Species Specificity | 1 | 1998 | 42 | 0.040 |
Why?
|
Models, Neurological | 1 | 1998 | 25 | 0.040 |
Why?
|
Lysophosphatidylcholines | 1 | 1997 | 8 | 0.040 |
Why?
|
Isotope Labeling | 1 | 1997 | 3 | 0.030 |
Why?
|
Physical Phenomena | 1 | 2016 | 3 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2015 | 5 | 0.030 |
Why?
|
Phosphatidylcholines | 1 | 2015 | 5 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 55 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 68 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2015 | 102 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2005 | 30 | 0.030 |
Why?
|
Male | 3 | 2001 | 15143 | 0.030 |
Why?
|
Mast Cells | 1 | 1993 | 18 | 0.030 |
Why?
|
Pulmonary Adenomatosis, Ovine | 1 | 2013 | 2 | 0.030 |
Why?
|
Jaagsiekte sheep retrovirus | 1 | 2013 | 2 | 0.030 |
Why?
|
Cricetulus | 1 | 2013 | 16 | 0.030 |
Why?
|
Antigens, Viral | 1 | 2013 | 9 | 0.030 |
Why?
|
Sheep | 1 | 2013 | 19 | 0.030 |
Why?
|
Cricetinae | 1 | 2013 | 40 | 0.030 |
Why?
|
ROC Curve | 2 | 2003 | 141 | 0.020 |
Why?
|
Rhodamines | 1 | 1991 | 5 | 0.020 |
Why?
|
Video Recording | 1 | 1991 | 35 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 1990 | 11 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 1990 | 77 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2005 | 3 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 23 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2005 | 25 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2006 | 31 | 0.020 |
Why?
|
Kidney | 1 | 2005 | 174 | 0.010 |
Why?
|
Quality Control | 1 | 2003 | 33 | 0.010 |
Why?
|
Proctoscopy | 1 | 2001 | 1 | 0.010 |
Why?
|
Proctoscopes | 1 | 2001 | 1 | 0.010 |
Why?
|
Arteries | 1 | 2001 | 14 | 0.010 |
Why?
|
Ligation | 1 | 2001 | 38 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 492 | 0.010 |
Why?
|
Fibrocystic Breast Disease | 1 | 2001 | 5 | 0.010 |
Why?
|
Fibroadenoma | 1 | 2001 | 6 | 0.010 |
Why?
|
Escherichia coli | 2 | 1991 | 55 | 0.010 |
Why?
|
Suture Techniques | 1 | 2001 | 155 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1999 | 4 | 0.010 |
Why?
|
3T3 Cells | 1 | 1999 | 10 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1999 | 37 | 0.010 |
Why?
|
Phenotype | 1 | 1999 | 306 | 0.010 |
Why?
|
Fluoresceins | 1 | 1997 | 6 | 0.010 |
Why?
|
Fluorometry | 1 | 1997 | 5 | 0.010 |
Why?
|
Molecular Structure | 1 | 1997 | 17 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1997 | 3 | 0.010 |
Why?
|
Gangliosides | 1 | 1997 | 6 | 0.010 |
Why?
|
Cobalt | 1 | 1997 | 113 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 1995 | 11 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 135 | 0.010 |
Why?
|
Freeze Fracturing | 1 | 1993 | 1 | 0.010 |
Why?
|
Peritoneal Cavity | 1 | 1993 | 2 | 0.010 |
Why?
|
Cytoplasmic Granules | 1 | 1993 | 5 | 0.010 |
Why?
|
Cell Degranulation | 1 | 1993 | 6 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1993 | 68 | 0.010 |
Why?
|
Electric Conductivity | 1 | 1993 | 69 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2001 | 4846 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 8 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 1993 | 449 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 1991 | 12 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1991 | 22 | 0.010 |
Why?
|
Plasmids | 1 | 1991 | 45 | 0.010 |
Why?
|
Papain | 1 | 1990 | 1 | 0.010 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1990 | 3 | 0.010 |
Why?
|
Glucosides | 1 | 1990 | 2 | 0.010 |
Why?
|
Acrylamides | 1 | 1990 | 3 | 0.010 |
Why?
|
Adult | 1 | 2001 | 8021 | 0.000 |
Why?
|
Middle Aged | 1 | 2001 | 9186 | 0.000 |
Why?
|
Aged | 1 | 2001 | 9222 | 0.000 |
Why?
|